Session 3

Session 3

2:00-4:00  

Moderator: Osama El Shamy, MD

2:00     Progress in Tackling Barriers to Home Dialysis in the United States – Osama El Shamy, MD

2:30     Racial and Ethnic Disparities in Home Dialysis – Katherine Rizzolo, MD

3:00     Early Nephrologist Performance in the Merit-Based Incentive Payment System – Kevin Erickson, MD

3:45     Discussion

4:00     Break

Dealing with Challenges “Difficult” Patients Present

Dealing with Challenges Non-traditional Patients Present

2:00-4:00

Moderator: LaVonne Burrows, MS, RN

2:00     Overview and Case Presentation – Lisa Koester, ANP, CNN-NP

2:15     Understanding the Provider Perspective:  Quality Metrics Facilities Are Measured for Reimbursement, Safety of Staff – Julie Williams, BSA

2:45     Understanding the Patient Perspective – Nieltje Gedney

3:15     Social Worker Role – Beth Witten, MSW, ACSW, LSCSW

3:40     Panel Discussion

4:00     Break

Fellows Forum

Fellows Forum

2:00-4:00pm

Moderator: Maria Camilla Bermudez

Judges: Vikram Aggarwal, MD; Maria Camilla Bermudez, MD; Anjay Rastogi, MD, PhD

2:00-2:30 Special Lecture – Mark Unruh, MD

2:30-2:45 A Missed Cause of High Output Cardiac Failure in a Kidney Transplant Recipient – Srilekha Sridhara, MD

2:45-2:50 Questions

2:50-3:05 Potential Value of Cystatin C as a Biomarker for Monitoring Renal Function in Duchenne Muscular Dystrophy – Muddassar Mahboob, MD

3:05-3:10 Questions

3:10-3:25 Hemodialysis Induced Asthma Exacerbation: Case Report – Sameena Hameed

3:25-3:30 Questions

3:30-3:45 Recurrent Pleural Effusions in a Peritoneal Dialysis Patient Requiring Pleurodesis – Maggy Marie Spolnik, MD

3:45-3:50 Questions

3:40-4:30 Break Early

4:30-4:45 New Onset of Shortness of Breath in a Peritoneal Dialysis Patient – Christian Nehme, MD

4:45-4:50 Questions

4:50-5:05 Outcome of Hemodialysis in Amyloidosis, Experience, and the Future – Zaid Al-Dahabrah, MD

5:05-5:10 Questions

5:10-5:25 Cloudy Effluent in a Peritoneal Dialysis Patient – Yesha Shah, DO

5:25-5:30 Questions

5:30-5:40 Judges Convene

5:40 Announce Winner/Adjourn

Tools of Trade: Impact of HD Technology on Patient Outcomes

Tools of Trade: Impact of HD Technology on Patient Outcomes

2:00-4:00

Moderator: Madhukar Misra, FRCP (UK), FASN

2:00     Monitoring Lung Congestion: What Can We Learn from the CHF Model? – Sandip Mitra MD, FRCP 

2:40     Clinical Significance of Achievable Reductions in B2 M levels – Are We Making a Difference? – Bernard Canaud, MD, PhD

3:20     Expanded Hemodialysis and Clinical Outcomes – Sandip Mitra MD, FRCP 

3:50     Discussion

4:00     Adjourn

Value-Based Care in Nephrology Part 1

Value-Based Care in Nephrology Part 1 

2:00-4:00

Moderator: Andrew Howard, MD

2:00     What Is Value-based Care? – Terry Ketchersid, MD, MBA

2:30     CMS Voluntary Payment Models: KCF, CKCC – Andrew Howard, MD, FACP

3:00     CMS Mandatory Payment Model: ESRD Treatment Choices – Michael Kraus, MD, FACP

3:30     Panel Discussion – Terry Ketchersid, MD, MBA; Michael Kraus, MD, FACP, Kevin Erickson, MD

4:00     Adjourn

PD Fundamentals – PD access

PD Fundamentals – PD access

2:00-4:00

Moderator: Osama El Shamy, MD

2:00      Traditional vs Embedded PD Catheter Insertion: What Are the Outcomes?  John Crabtree, MD

2:30     Surgical Laparoscopic vs Percutaneous PD Catheter Placement – Rajeev Narayan, MD

3:00      Surgical Management of Common Mechanical and Infectious Complications – John Crabtree, MD

3:30      Practical Approach to Create and Maintain a Successful PD Catheter – Shweta Bansal, MD, FASN

3:55       Discussion

4:00     Adjourn

Workshop: PD Prescription Workshop

Workshop: PD Prescription Workshop

2:00-4:00

Moderator: Anjay Rastogi, MD, PhD

Speakers: Anjay Rastogi, MD, PhD, Ramesh Khanna, MD and Jeffrey Perl, MD, FRCP

Peritoneal dialysis prescription involves more than just adjusting prescription to meet target KT/V urea or creatinine clearances.  Areas that not emphasized enough include BP control, and fluid and electrolytes balances and fluid management. This workshop will help you recognize important factors to consider when prescribing PD.  Additionally, we will point out the 10 common mistakes made when prescribing PD.

Implementing Evidence-based Clinical Practice

Implementing Evidence-based Clinical Practice

2:00-4:00

Presented in Cooperation with Kidney Disease: Improving Global Outcomes (KDIGO)

Moderator: Ramesh Khanna, MD

2:00     Symptom Assessment in Dialysis Patients – Jenny Flythe, MD

2:30     Q and A

2:40     Reducing the Burden of Symptoms – Rajnish Mehrotra, MD

3:10     Q and A

3:20     Systems-Level Opportunities Symptom Management – Mark Unruh, MD

3:50     Q and A

4:00     Adjourn

Session 8: – Updated Peritonitis Guidelines

Session 8: – Updated Peritonitis Guidelines

2:00-4:00 pm

Moderator(s): Franz Schaefer, MD and Bradley Warady, MD

2:00     Care Delivery and Outcomes in Children Treated with Maintenance Dialysis. – Elaine Ku, MD
2:25     The Development of Evidence-based Guidelines – Reem Mustafa, MD
2:50     The Use of Registry-based Data in Guideline Development – Troy Richardson, MD
3:15     Highlights of the Upcoming Pediatric Peritonitis Guidelines – Brandy Begin, BSN, MBA, RN, CNN
3:40     Discussion
4:00     Break

RD Breakout II

RD Breakout II

2:00-4:00 pm

Moderator(s):  Nonnie Polderman, BSc, RD

2:00     Vitamin and Mineral Supplementation for Pediatric Dialysis Patients – Caroline Anderson, PhD, RD
3:00     Carnitine Supplementation – Marisa Juarez-Calderon, RD
4:00     Break